InvestSMART

Firebrick Pharma Limited (ASX: FRE) - Announcements

Current share price for FRE : $0.033 0.001 (3.13%)+

ASX company news and announcements for Firebrick Pharma Limited (FRE) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Firebrick Pharma Limited (FRE) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Firebrick Pharma Limited (FRE), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Firebrick Pharma Limited (FRE)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$9 Cleansing Notice 13 Feb 2026 9:30AM $0.063 $0.033 fallen by 47.62%
$9 Application for quotation of securities - FRE 13 Feb 2026 9:27AM $0.063 $0.033 fallen by 47.62%
$9 Proposed issue of securities - FRE 12 Feb 2026 10:58AM $0.063 $0.033 fallen by 47.62%
$9 Notification regarding unquoted securities - FRE 11 Feb 2026 11:21AM $0.065 $0.033 fallen by 49.23%
$9 Proposed issue of securities - FRE 10 Feb 2026 9:14AM $0.065 $0.033 fallen by 49.23%
$9 Firebrick Appoints New Independent Director 10 Feb 2026 8:19AM $0.065 $0.033 fallen by 49.23%
$9 December 2025 Quarterly Activity Report & Appendix 4C 28 Jan 2026 8:18AM $0.065 $0.033 fallen by 49.23%
$9 Nasodine Throat Spray Product Launch in Fiji 22 Jan 2026 8:27AM $0.063 $0.033 fallen by 47.62%
$9 Nasodine Throat Spray Product Launch in Singapore 21 Jan 2026 8:23AM $0.063 $0.033 fallen by 47.62%
$9 Update on Registration of Nasodine in the Philippines 12 Jan 2026 8:32AM $0.066 $0.033 fallen by 50%
$9 Results of Annual General Meeting 26 Nov 2025 11:42AM $0.065 $0.033 fallen by 49.23%
$9 Annual General Meeting Presentation 2025 26 Nov 2025 8:24AM $0.064 $0.033 fallen by 48.44%
$9 Notice of Change of Auditor 21 Nov 2025 8:46AM $0.065 $0.033 fallen by 49.23%
$9 Firebrick announces new product Nasodine Throat Spray 30 Oct 2025 9:52AM $0.064 $0.033 fallen by 48.44%
$9 Notice of AGM & Proxy Form & Letter to Shareholders 27 Oct 2025 10:58AM $0.063 $0.033 fallen by 47.62%
$9 September 2025 Quarterly Activity Report & Appendix 4C 23 Oct 2025 8:22AM $0.062 $0.033 fallen by 46.77%
$9 Becoming a substantial holder - Pharma Nutria NA Inc 17 Oct 2025 8:27AM $0.067 $0.033 fallen by 50.75%
$9 Cleansing Notice 17 Oct 2025 8:27AM $0.067 $0.033 fallen by 50.75%
$9 Application for quotation of securities - FRE 17 Oct 2025 8:27AM $0.067 $0.033 fallen by 50.75%
$9 Proposed issue of securities - FRE 16 Oct 2025 9:57AM $0.065 $0.033 fallen by 49.23%
$9 Firebrick Secures Investment from Philippines Partner 16 Oct 2025 9:53AM $0.065 $0.033 fallen by 49.23%
$9 Notification regarding unquoted securities - FRE 2 Oct 2025 9:07AM $0.066 $0.033 fallen by 50%
$9 Notice of AGM and Closing Date for Director Nominations 29 Sep 2025 8:28AM $0.063 $0.033 fallen by 47.62%
$9 Final Director's Interest Notice - Phyllis Gardner 12 Sep 2025 8:25AM $0.065 $0.033 fallen by 49.23%
$9 Passing of Director - Phyllis Gardner 11 Sep 2025 10:44AM $0.070 $0.033 fallen by 52.86%

51 - 75 of 507 results

Page 3 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.